Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on sleep in brain health

LIVE: Thursday 2nd May 2024, 18:00-19:30 (CEST)

Quality sleep is essential for health. But what happens to our brains when sleep patterns are disturbed? Join our experts to explore the interplay between sleep disruption and neurological diseases, and the questions that you need to be asking your patients to help you prevent the harmful effects of sleep deprivation.
ADVANCED SEARCH
Log in
Top
Current Urology Reports
Published in: Current Urology Reports 1/2019

01-01-2019 | Kidney Transplantation | Kidney Diseases (G Ciancio, Section Editor)

Use of Mannitol for Ischemia Reperfusion Injury in Kidney Transplant and Partial Nephrectomies—Review of Literature

Authors: Jose Alejandro Lugo-Baruqui, Rajinikanth Ayyathurai, Adavan Sriram, Kothai Divya Pragatheeshwar

Published in: Current Urology Reports | Issue 1/2019

Login to get access

Abstract

Purpose of Review

Few procedures involve the ischemia-reperfusion injury to organs purposely. Two clear examples in urologic surgery consist on kidney transplantation and partial nephrectomies.

Recent Findings

Mannitol is an osmotic diuretic that is commonly used in partial nephrectomies and kidney transplantation to increase renal blood flow and decrease warm-ischemia-related renal injury to preserve estimated glomerular filtration rate (eGFR).

Summary

We review the current evidence for the use of mannitol and its effects on these procedures.
Literature
1.
Volpe A, Cadeddu JA, Cestari A, Gill IS, Jewett MAS, Joniau S, et al. Contemporary management of small renal masses. Eur Urol. 2011;60:501–15.CrossRef
2.
Bjurlin MA, Walter D, Taksler GB, Huang WC, Wysock JS, Sivarajan G, et al. National trends in the utilization of partial nephrectomy before and after the establishment of AUA guidelines for the management of renal masses. Urology. 2013;82:1283–90.CrossRef
3.
• Shawkat H, Westwood M, Mortimer A. Mannitol: a review of its clinical uses. Contin Educ Anaesth Crit Care Pain. 2012;12(2):82–5 Comprehensive pharmacological review of mannitol, itls clinical uses in anesthesiology, and side effects. CrossRef
4.
Johnston PA, Bernard DB, Perrin NS, Levinsky NG. Prostaglandins mediate the vasodilatory effect of mannitol in the hypoperfused rat kidney. J Clin Invest. 1981;68:127–33.CrossRef
5.
• Bugge JF, Hartmann A, Osnes S, Bentdal O, Stenstrøm J. Immediate and early renal function after living donor transplantation. Nephrol Dial Transplant. 1999;14(2):389–93 Classic paper that describes normalization of renal function of kidneys transplanted from living donors after volume expansion comb ined with the use of mannitol and furosemide. CrossRef
6.
P S, van der Woude FJ. Perioperative fluid management in renal transplantation: a narrative review of the literature. Transpl Int. 2006;19(12):947–59.CrossRef
7.
8.
van Valenberg PL, Hoitsma AJ, Tiggeler RG, Berden JH, van Lier HJ, Koene RA. Mannitol as an indispensable constituent of an intraoperative hydration protocol for the prevention of acute renal failure after renal cadaveric transplantation. Transplantation. 1987;44(6):784–8.CrossRef
9.
10.
Hanif F, Macrae AN, Littlejohn MG, Clancy MJ, Murio E. Outcome of renal transplantation with and without intra-operative diuretics. Int J Surg. 2011;9:460–3.CrossRef
11.
Tiggeler RG, Berden JH, Hoitsma AJ, Koene RA. Prevention of acute tubular necrosis in cadaveric kidney transplantation by the combined use of mannitol and moderate hydration. Ann Surg. 1985;201:246–51.CrossRef
12.
Weimar W, Geerlings W, Bijnen AB, et al. A controlled study on the effect of mannitol on immediate renal function after cadaver donor kidney transplantation. Transplantation. 1983;35:99.PubMed
13.
Namnesnikov M, Fedorov D, Abu-Gazala S, Weinbroum AA, Khoury W. Mannitol attenuates kidney damage induced by xanthine oxidase-associated pancreas ischemia-reperfusion. J Surg Res. 2010;160(1):163–8.CrossRef
14.
•• Andrews PM, Cooper M, Verbesey J, Ghasemian S, Rogalsky D, Moody P, et al. Mannitol infusion within 15 min of cross-clamp improves living donor kidney preservation. Transplantation. 2014;98(8):893–7 Classic paper with clinical evidence for the use of mannitol in kidney transplant. CrossRef
15.
Esfahani HS, Nooraei N, Asgary M, Hashemian MR. The effect of mannitol administration to kidney donor on short-term outcomes of kidney transplantation. Saudi J Kidney Dis Transpl. 2014;25(6):1154–9.CrossRef
16.
Prerez-Perez AJ, Pazos B, Sobrado J, Gonzalez L, Gandara A. Acute renal failure following massive mannitol infusion. Am J Nephrol. 2002;22:573–5.CrossRef
17.
Power NE, Maschino AC, Savage C, Silberstein JL, Thorner D, Tarin T, et al. Intraoperative mannitol use does not improve long-term renal function outcomes after minimally invasive partial nephrectomy. Urology. 2012;79:821–6.CrossRef
18.
Omae K, Kondo T, Takagi T, Iizuka J, Kobayashi H, Hashimoto Y, et al. Mannitol has no impact on renal function after open partial nephrectomy in solitary kidneys. Int J Urol. 2014;21:200–3.CrossRef
19.
Spaliviero M, Power NE, Murray KS, Sjoberg DD, Benfante NE, Bernstein ML, et al. Intravenous mannitol versus placebo during partial nephrectomy in patients with Normal kidney function: a double-blind, clinically-integrated, randomized trial [Figure presented]. Eur Urol. 2018;73:53–9.CrossRef
20.
21.
Novick AC. Renal hypothermia: in vivo and ex vivo. Urol Clin North Am. 1983;10(4):637-44
22.
Gelman S. Does mannitol save the kidney? Anesth Analg. 1996;82(5):899-901
23.
Metadata
Title
Use of Mannitol for Ischemia Reperfusion Injury in Kidney Transplant and Partial Nephrectomies—Review of Literature
Authors
Jose Alejandro Lugo-Baruqui
Rajinikanth Ayyathurai
Adavan Sriram
Kothai Divya Pragatheeshwar
Publication date
01-01-2019

Other articles of this Issue 1/2019

Current Urology Reports 1/2019 Go to the issue

Kidney Diseases (G Ciancio, Section Editor)

A Critical Insight into the Clinical Translation of PD-1/PD-L1 Blockade Therapy in Clear Cell Renal Cell Carcinoma

Kidney Diseases (G Ciancio, Section Editor)

Vascular Injury During Urologic Surgery: Somebody Call My Mother

Kidney Diseases (G Ciancio, Section Editor)

Imaging of Unusual Renal Tumors

Kidney Diseases (G Ciancio, Section Editor)

Surgical Treatment of Completely Endophytic Renal Tumor: a Systematic Review

Kidney Diseases (G Ciancio, Section Editor)

Renal Medullary Carcinoma: a Report of the Current Literature